Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corvus Pharmaceuticals (CRVS) Prepaid Assets: 2022-2024

Historic Prepaid Assets for Corvus Pharmaceuticals (CRVS) over the last 3 years, with Dec 2024 value amounting to $2.4 million.

  • Corvus Pharmaceuticals' Prepaid Assets rose 1.92% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 1.92%. This contributed to the annual value of $2.4 million for FY2024, which is 203.20% up from last year.
  • As of FY2024, Corvus Pharmaceuticals' Prepaid Assets stood at $2.4 million, which was up 203.20% from $781,000 recorded in FY2023.
  • Corvus Pharmaceuticals' Prepaid Assets' 5-year high stood at $2.4 million during FY2024, with a 5-year trough of $773,000 in FY2022.
  • Moreover, its 3-year median value for Prepaid Assets was $781,000 (2023), whereas its average is $1.3 million.
  • Data for Corvus Pharmaceuticals' Prepaid Assets shows a peak YoY surged of 203.20% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Corvus Pharmaceuticals' Prepaid Assets stood at $773,000 in 2022, then grew by 1.03% to $781,000 in 2023, then soared by 203.20% to $2.4 million in 2024.